Overview
The DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver regeneration compared to standard PVE. This collaborative registry focuses on identifying associations between baseline clinical/imaging parameters, clinical outcomes, and safety for patients undergoing PVE/HVE.
Description
Retrospective and prospective
Eligibility
Inclusion Criteria:
- Patients who have undergone PVE/HVE or technical variations on this procedure
- 18 Years and older
- Men and women


